Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: Immunohistochemical studies and mutation analysis of the p53 gene

Awaya, 2005, Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma, Pathol. Int., 55, 14, 10.1111/j.1440-1827.2005.01784.x Awaya, 2004, Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung, Am. J. Clin. Pathol., 121, 644, 10.1309/U4WGE9EBFJN6CM8R Clayton, 1986, Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates, Cancer, 57, 1555, 10.1002/1097-0142(19860415)57:8<1555::AID-CNCR2820570820>3.0.CO;2-N Colby, 2004, Adenocarcinoma Goldstein, 2001, Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies, Am. J. Clin. Pathol., 116, 319, 10.1309/550P-QLJX-D84W-F6DN Hidaka, 1998, Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study, Mod. Pathol., 11, 1039 Koga, 2001, Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma, Clin. Cancer Res., 7, 1730 Lau, 2002, Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases, Mod. Pathol., 15, 538, 10.1038/modpathol.3880560 Maeshima, 2002, Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K-ras gene mutation, Virchows Arch., 440, 598, 10.1007/s00428-002-0629-6 Marchetti, 1998, FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations, J. Pathol., 184, 240, 10.1002/(SICI)1096-9896(199803)184:3<240::AID-PATH20>3.0.CO;2-B Moriya, 2001, Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases, Cancer, 91, 1129, 10.1002/1097-0142(20010315)91:6<1129::AID-CNCR1109>3.0.CO;2-C Ohori, 2004, Cytopathologic diagnosis of bronchioloalveolar carcinoma: does it correlate with the 1999 World Health Organization definition?, Am. J. Clin. Pathol., 122, 44, 10.1309/VXBME9Y66WGM090V Saad, 2004, Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung, Hum. Pathol., 35, 3, 10.1016/j.humpath.2003.08.011 Sakurai, 2004, Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment, Ann. Thorac. Surg., 78, 1728, 10.1016/j.athoracsur.2004.05.017 Sarantopoulos, 2004, Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation, Arch. Pathol. Lab. Med., 128, 406, 10.5858/2004-128-406-IAOLCW Shah, 2002, Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma, Hum. Pathol., 33, 915, 10.1053/hupa.2002.126876 Terasaki, 2003, Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization, Am. J. Surg. Pathol., 27, 937, 10.1097/00000478-200307000-00009 Yamasaki, 2000, Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung, Pathol. Int., 50, 778, 10.1046/j.1440-1827.2000.01123.x